CAS: 897657-95-3
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
MSX-122 REF: AN-AG00GU9PCAS: 897657-95-3 | ≥98% | To inquire | Fri 10 May 24 | |
MSX-122 REF: TM-T3992CAS: 897657-95-3 | 98.78% | 63.00 €~1,003.00 € | Fri 17 May 24 | |
MSX-122 REF: 3D-XKB65795CAS: 897657-95-3 | Min. 95% | To inquire | Fri 21 Jun 24 |
Ref: AN-AG00GU9P
1mg | 74.00 € | |
5mg | 134.00 € | |
10mg | 198.00 € | |
25mg | 297.00 € | |
50mg | 622.00 € | |
100mg | To inquire | |
500mg | To inquire |
Estimated delivery in United States, on Friday 10 May 2024
MSX-122
CAS:897657-95-3
MSX-122 is a novel small molecule and partial CXCR4 antagonist, with potent inhibition of CXCR4/CXCL12 …
Formula:
C16H16N6
Purity:
98.78%
Color and Shape:
Solid
Molecular weight:
292.34
Ref: TM-T3992
5mg | 63.00 € | |
10mg | 95.00 € | |
25mg | 185.00 € | |
50mg | 322.00 € | |
100mg | 476.00 € | |
500mg | 1,003.00 € |
Estimated delivery in United States, on Friday 17 May 2024
MSX-122
CAS:897657-95-3
MSX-122 is a potent chemokine receptor CXCR4 inhibitor that has been shown to inhibit HIV …
Formula:
C16H16N6
Purity:
Min. 95%
Molecular weight:
292.34 g/mol
Ref: 3D-XKB65795
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 21 Jun 2024